The Moral and Strategic Calculus of Voting for Joe Biden to Defeat Trump — or Not
Is voting for Biden, a terrible candidate, the only principled position to fight Trump?
1,354 posts found for ‘content’
Border Patrol Chief Carla Provost Was a Member of Secret Facebook Group
Three months after her appointment as chief of the Border Patrol, Carla Provost posted in the “I’m 10-15” Facebook group.
How U.S. Tech Giants Are Helping to Build China's Surveillance State
A nonprofit led by Google and IBM executives is working with Semptian, whose technology is monitoring the internet activity of 200 million people in China.
Purdue Pharma Hired PR Firm That Rebranded BP After Deepwater Horizon Spill
The relationship was disclosed in Purdue’s recent filing for Chapter 11 bankruptcy protection.
Watch: The Grave, Three-Pronged Crisis Crippling Brazil and Imperiling the Bolsonaro Presidency
The confluence of these crises has placed Brazil in the greatest turmoil and danger since its 1985 redemocratization.
Documents Shed New Light on Critical Moment in Pete Buttigieg's South Bend Political Career
An investigation by the Young Turks sheds new light on a moment Buttigieg has highlighted as defining his relationship with South Bend’s black community.
The Rise of Smart Camera Networks, and Why We Should Ban Them
Police are using cameras at private businesses and homes, along with AI, to expand their video surveillance — raising privacy concerns.
The FBI Spends a Lot of Time Spying on Black Americans
The FBI released a new trove of documents relating to its surveillance of black activists. They’re mostly redacted.
The Trump Administration Is Using the Full Power of the U.S. Surveillance State Against Whistleblowers
An examination of court filings in all seven leak cases filed under Trump yields a detailed picture of how the government tries to unmask confidential sources.
Kamala Harris Receives Donations From Big Pharma Executives Despite Claim She Rejects Them
Campaign finance records show Harris has received thousands of dollars from executives at drug companies and distributors this year; most were not returned.